Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus

American Journal of Cardiology

Volumn 80, Issue 2, 1997, Pages 164-169

  Agewall, Stefan ^a   Wikstrand, John ^a   Ljungman, Susanne ^a   Fagerberg, Björn ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PERFORMANCE; DIABETES MELLITUS; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL;

AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; HUMANS; HYPERTENSION; INTERVENTION STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0030741927     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00312-3     Document Type: Article

References (24)

1. Kannel WB, Stampfer MJ, Castelli WP, Verter J. The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984;108:1347-1352.
2. Samuelsson O, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, Berglund G. Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, Sweden. J Hypertens 1985;3:167-176.
3. Agewall S, Ljungman S, Herlitz H, Wikstrand J, Fagerberg B. Does microalbuminuria predict cardiovascular disease in non-diabetic men with treated hypertension? Am J Hypertens 1995;8:337-342.
4. Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 1988;5:126-134.
5. Jarett RJ, Viberti GC, Argyropoulus A, Hill RD, Mahmud U, Murrels TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabet Med 1984;1:17-19.
6. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992;41:736-741.
7. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995;44:1303-1309.
8. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 1992;41:731-735.
9. Messent WC, Elliott TG, Hill RD, Jarett RJ, Keen H, Viberti G. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992;41:836-839.
10. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 1988;2:530-533.
11. Agewall S, Persson B, Samuelsson O, Ljungman S, Herlitz H, Fagerberg B. Microalbumimiria in treated hypertensive men at high risk of coronary disease. J Hypertens 1993;11:461-469.
12. Agewall S, Samuelsson O, Andersson OK, Persson B, Wikstrand J, Fagerberg B. The efficacy of multiple risk factor intervention in treated hypertensive men, during long term follow-up. J Int Med 1994;236:651-659.
13. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, Vedin A, Wilhelmsson C, Werkö L. The multifactorial primary prevention trial in Gothenburg, Sweden. Eur Heart J 1986;7:279-288.
14. World Health Organisation Study Group. Diabetes mellitus: WHO Tech Rep Ser 1985; no 727.
15. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I. Causes and death rates. Diabetologia 1990;33:538-541.
16. Ljungman S, Wikstrand J, Hartford M, Berglund G. Urinary albumin excretion - A predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged non-diabetic normal and hypertensive men. Am J Hypertens 1996;9:770-778.
17. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989;32:219-226.
18. Feldt-Rasmussen B. Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1986;29:282-286.
19. Nannipieri M, Rizzo L, Raputano A, Pilo A, Penno G, Navalesi R. Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care 1995;18:1-9.
20. Haffner SM, Stern MP, Kozlowski Gruber MK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990; 10:727-731.
21. Agewall S, Fagerberg B, Attvall S, Ljungman S, Urbanavicius V, Tengborn L, Wikstrand J. Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. J Int Med 1995;237:195-203.
22. Groop L, Ekstrand A, Forsblom C, Widén A, Groop P-H, Teppo AM, Eriksson J. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993;36:642-647.
23. Pedrinelli R, Di Bello V, Catapano G, Talarico L, Materazzi F, Santoro G, Giusti C, Mosca F, Melillo E, Ferrari M. Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients. Arterioscler Thromb 1993;13:900-906.
24. Agewall S, Fagerberg B, Ljungman S, Wikstrand J. Urinary albumin excretion is associated with intima-media thickness of the carotid artery in hypertensive men with non-insulin-dependent diabetes mellitus. J Hypertens 1995;13:463-469.